GBIO Financial Analysis
GBIO Key Indicators
GBIO Income Statement
GBIO Balance Sheet
GBIO Cash Flow
Quarterly
| FY2024Q4 | FY2024Q3 | FY2024Q2 | FY2024Q1 | FY2023Q4 | FY2023Q3 | FY2023Q2 | FY2023Q1 | FY2022Q4 | FY2022Q3 | FY2022Q2 | FY2022Q1 | FY2021Q4 | FY2021Q3 | FY2021Q2 | FY2021Q1 | FY2020Q4 | FY2020Q3 | FY2020Q2 | FY2020Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Assets | 231.20M -38.31% | 248.78M -34.79% | 265.26M -34.48% | 285.88M -33.73% | 374.76M -0.40% | 381.49M -5.29% | 404.88M -3.37% | 431.42M -2.84% | 376.26M -21.08% | 402.80M -13.20% | 418.99M -14.63% | 444.03M -13.63% | 476.77M 62.08% | 464.03M 49.24% | 490.79M 48.19% | 514.08M 287.59% | 294.16M | 310.92M | 331.20M | 132.64M |
Total Current Assets | 192.90M -29.24% | 191.25M -35.78% | 223.28M -30.36% | 226.85M -34.20% | 272.62M -5.02% | 297.81M -4.11% | 320.62M -0.16% | 344.73M 0.93% | 287.02M -24.31% | 310.56M -22.99% | 321.13M -25.79% | 341.56M -25.06% | 379.19M 41.63% | 403.27M 41.10% | 432.74M 41.34% | 455.79M 324.81% | 267.74M | 285.81M | 306.18M | 107.29M |
Total Non-Current Assets | 38.29M -62.51% | 57.53M -31.25% | 41.98M -50.17% | 59.03M -31.90% | 102.14M 14.45% | 83.68M -9.28% | 84.26M -13.90% | 86.68M -15.40% | 89.25M -8.54% | 92.24M 51.80% | 97.86M 68.58% | 102.46M 75.76% | 97.59M 269.36% | 60.76M 142.00% | 58.05M 131.97% | 58.30M 130.02% | 26.42M | 25.11M | 25.03M | 25.34M |
Total Liabilities | 144.99M -15.52% | 144.34M -3.50% | 149.86M -0.49% | 153.89M 1.06% | 171.63M 83.03% | 149.58M 59.04% | 150.60M 60.00% | 152.28M 67.13% | 93.77M -1.32% | 94.05M 65.51% | 94.12M 64.00% | 91.11M 64.62% | 95.03M 263.50% | 56.82M 133.04% | 57.39M 112.17% | 55.35M 142.08% | 26.14M | 24.38M | 27.05M | 22.86M |
Total Current Liabilities | 35.06M -12.17% | 30.17M -8.09% | 30.10M 13.69% | 28.31M 24.52% | 39.91M 108.43% | 32.82M 89.51% | 26.48M 63.60% | 22.74M 49.06% | 19.15M 1.82% | 17.32M 19.39% | 16.19M 16.18% | 15.25M 41.32% | 18.81M 67.63% | 14.51M 58.31% | 13.93M 20.76% | 10.79M 52.18% | 11.22M | 9.16M | 11.54M | 7.09M |
Total Non-Current Liabilities | 109.94M -16.53% | 114.18M -2.21% | 119.75M -3.52% | 125.58M -3.06% | 131.72M 76.51% | 116.76M 52.16% | 124.12M 59.26% | 129.54M 70.77% | 74.62M -2.09% | 76.73M 81.33% | 77.94M 79.33% | 75.86M 70.27% | 76.22M 410.77% | 42.32M 178.04% | 43.46M 180.15% | 44.55M 182.52% | 14.92M | 15.22M | 15.51M | 15.77M |
Total Shareholders' Equity | 86.20M -57.56% | 104.44M -54.97% | 115.41M -54.62% | 131.99M -52.71% | 203.13M -28.09% | 231.91M -24.89% | 254.29M -21.73% | 279.14M -20.90% | 282.49M -26.00% | 308.75M -24.18% | 324.87M -25.04% | 352.92M -23.07% | 381.75M 42.44% | 407.21M 42.11% | 433.40M 42.49% | 458.74M 317.89% | 268.01M | 286.54M | 304.15M | 109.77M |
Shareholders' Equity | 86.20M -57.56% | 104.44M -54.97% | 115.41M -54.62% | 131.99M -52.71% | 203.13M -28.09% | 231.91M -24.89% | 254.29M -21.73% | 279.14M -20.90% | 282.49M -26.00% | 308.75M -24.18% | 324.87M -25.04% | 352.92M -23.07% | 381.75M 42.44% | 407.21M 42.11% | 433.40M 42.49% | 458.74M 317.89% | 268.01M | 286.54M | 304.15M | 109.77M |
Total Liabilities & Equity | 231.20M -38.31% | 248.78M -34.79% | 265.26M -34.48% | 285.88M -33.73% | 374.76M -0.40% | 381.49M -5.29% | 404.88M -3.37% | 431.42M -2.84% | 376.26M -21.08% | 402.80M -13.20% | 418.99M -14.63% | 444.03M -13.63% | 476.77M 62.08% | 464.03M 49.24% | 490.79M 48.19% | 514.08M 287.59% | 294.16M | 310.92M | 331.20M | 132.64M |
Net Debt | -185.22M -29.94% | -184.77M -36.51% | -216.94M -30.94% | -219.30M -24.02% | -264.36M -5.28% | -291.03M -3.37% | -314.14M 0.62% | -288.65M -14.34% | -279.09M -25.60% | -301.17M -24.40% | -312.20M -26.57% | -336.98M -25.30% | -375.15M 43.01% | -398.36M 42.09% | -425.19M 41.22% | -451.08M 331.77% | -262.33M | -280.37M | -301.09M | -104.47M |
Working Capital | 157.85M -32.17% | 161.09M -39.21% | 193.18M -34.33% | 198.54M -38.34% | 232.70M -13.13% | 264.99M -9.63% | 294.14M -3.54% | 322.00M -1.32% | 267.87M -25.67% | 293.24M -24.57% | 304.95M -27.19% | 326.31M -26.67% | 360.38M 40.49% | 388.76M 40.53% | 418.81M 42.14% | 444.99M 344.11% | 256.52M | 276.65M | 294.64M | 100.20M |
Free Financial AI Agent for Investment
Ask any investment related question and get answer instantly
Is GBIO earnings result positive or negative?How should I trade on GBIO earnings?GBIO FAQs
What is GBIO's PE Ratio in 2025/4/4?
GBIO's PE ratio in April 4, 2025 is -0.19. This indicates the price investors are willing to pay for $1 of earnings.
What is GBIO's PS Ratio in 2025/4/4?
GBIO's PS ratio in April 4, 2025 is 1.34. This indicates how much investors are willing to pay for each dollar of the company's sales.
What is GBIO's Dividend Yield in 2024/Q4?
GBIO's Dividend Yield in 2024/Q4 is 0.00%. This represents the return on investment from dividends relative to the stock price.
What is GBIO's Gross Margin in 2024/Q4?
GBIO's Gross Margin in 2024/Q4 is 100.00. Gross Margin is typically calculated as (Revenue - Cost of Goods Sold) / Revenue and is a key indicator of a company's financial health and efficiency in managing production costs.
Free Financial AI Agent for Investment
Ask any investment related question and get answer instantly
Is GBIO earnings result positive or negative?How should I trade on GBIO earnings?